Products

Voyage

short-lived full-stack deployment previews w/ feedback tools

voyageapp.io Software Development / Hosting, Deployment & DevOps

AI Benchmark
Monthly visits
None yet
No traffic data yet
MRR
$760Claimed
Disclosed 2026-09-29Indie Hackers
Entry price
Unknown
No monthly subscription pricing
Creators
Daniel France
@roast_or_toast· 758 followers
Launched
5y ago
2020-11-16 · Est.

Traffic & revenue

Monthly visits

No traffic data yet.

MRRSelf-reported, unverified · Indie Hackers
  • Sep 2026$760Self-reported MRR · unverified
Events1 revenue disclosure

Revenue evidence

Publicly disclosed & verified revenue figures, sorted by date

Marketing moves

Launches, search & content, referrals, promotions
X accounts@roast_or_toast@tryvoyage

  • Launched on BetaListLaunch

    Voyage – Creates complete isolated environments with every PR — Creates complete isolated environments with every PR

    Nov 16, 2020 · 5y agoLaunch page

Traffic sources

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority 21Domain registered 2020-02-10

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-08-11

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

    Changes

    No pricing, plan, or positioning changes detected since tracking started.

    Questions & evidence

    What is Voyage and what platforms does it support?
    Voyage is catalogued under Hosting, Deployment & DevOps: short-lived full-stack deployment previews w/ feedback tools. Supported platforms: Web.
    What is Voyage's publicly disclosed revenue?
    Indie Hackers records a founder-reported figure of $760 /mo stated on 2026-09-29.Source

    Related products in this category

    Software Development / Hosting, Deployment & DevOps

    These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.